Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing

This document A59018 is a response to public comments on MolDX LCD L39003 and records administrative details: comment period (5/20/2021–7/3/2021), notice period start (3/3/2022), and effective date (4/17/2022). It documents a title revision of the LCD to 'MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing' but does not itself specify clinical coverage criteria, limitations, documentation requirements for claims, or frequency limits.

"This document is a response to public comments on MolDX LCD L39003; it records the comment period (2021-05-20 to 2021-07-03), notice period start (2022-03-03), and effective date (2022-04-17) and n..."

Sign up to see full coverage criteria, indications, and limitations.